Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native Coronaries (TRYTON)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Tryton Medical, Inc.
ClinicalTrials.gov Identifier:
NCT01258972
First received: December 9, 2010
Last updated: April 20, 2016
Last verified: April 2016